Article ID Journal Published Year Pages File Type
2915054 European Journal of Vascular and Endovascular Surgery 2008 8 Pages PDF
Abstract

Objectives/DesignCarotid plaque echogenicity quantified by the Gray-Scale Median (GSM) score has been associated with plaque vulnerability. The aim of this study was to assess whether intensive lipid-lowering treatment with atorvastatin in patients with carotid artery stenosis ameliorates novel vascular calcification inhibitors, such as osteopontin (OPN) and osteoprotegerin (OPG), and improves GSM score.MethodsNinety-seven patients with carotid stenosis (>40%), but without indication for intervention, were treated for 6 months with atorvastatin (10 mg–80 mg) to target LDL < 100 mg/dl. Fifty-two age-and sex-matched healthy individuals served as the control group. Blood samples and GSM were obtained at the beginning and after 6 months.ResultsSystolic blood pressure, hsCRP, fibrinogen, OPN and OPG levels differed significantly between patients with carotid stenosis and healthy controls at baseline (p < 0.05). Atorvastatin treatment improved lipid profile and significantly reduced hsCRP (p = 0.002), WBC count (p = 0.041), OPN (p < 0.001) and OPG levels (p < 0.001). GSM score increased considerably after atorvastatin therapy (from 58.33 ± 24.38 to 79.33 ± 22.3; p < 0.001) and that effect appeared related to OPN (p = 0.001), OPG (p = 0.013) and LDL (p = 0.01) reduction.ConclusionsIn patients with carotid stenosis, intensive lipid-lowering therapy with statins attenuates serum OPN and OPG levels and enhances carotid plaque echogenicity, outlining their beneficial effects on plaque stability.

Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Authors
, , , , , , , , , , , , ,